Inspira Technologies OXY B.H.N. Ltd.
IINN | NASDAQ
$1.05
$0.00 (0.00%)
Nov 2, 2026, 11:20 AM ET · Market open
Company Profile
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Key Executives
| Name | Position |
|---|---|
| Dagi Shahar Ben-Noon | Co-Founder, Chief Executive Officer & Director |
| Avi Shabtai | Chief Operating Officer and Vice President of Research & Development |
| Daniella Yeheskely-Hayon | Chief Technology Officer |
| Yafit Tehila | Chief Financial Officer |
| Adi Shmueli | Director of Marketing |
| Mike Hershkovitz | Vice President of Global Sales |
| Sivan Ozeri | Administrative Manager |
| Yoav Rozanovich | Chief Business Officer |
Inspira Technologies OXY B.H.N. Ltd.
| Country | Israel |
| IPO Date | Jul 14, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 39 |
| CEO | Dagi Shahar Ben-Noon |
Contact Details
2 Ha-Tidhar St. Ra'anana 4366504 Israel
Stock Details
| Ticker Symbol | IINN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001837493 |
| CUSIP Number | M5S26K102 |
| ISIN Number | IL0011715781 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove IINN